Droxidopa Capsule
Product Images NDC 50228-429

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 50228-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Droxidopa 100mg 1000 (Droxidopa 100mg 1000ct)

Droxidopa Capsules 100 mg oral dosage form label by ScieGen Pharmaceuticals Inc. The label indicates each capsule contains 100 mg of droxidopa. It states storage conditions, dispensing instructions, warning to keep out of reach of children, and packaging quantity of 1000 capsules. Includes barcode, lot and expiration date fields, and manufacturer information.*

FDA Label Image

Droxidopa 100mg 30 (Droxidopa 100mg 30ct)

The label for Droxidopa Capsules, 100 mg oral capsules, displays the product name prominently with dosage strength below. It indicates a package size of 30 capsules and states 'Rx only.' The label includes storage instructions, a warning to keep out of reach of children, and manufacturer information for ScieGen Pharmaceuticals Inc., Hauppauge, NY. It also features an NDC number and a barcode.*

FDA Label Image

Droxidopa 100mg 90 (Droxidopa 100mg 90ct)

Label for Droxidopa Capsules 100 mg by ScieGen Pharmaceuticals Inc. The label indicates 90 capsules per bottle, with storage instructions and warnings. The NDC number 50228-429-90 is shown along with barcode and manufacturer details.*

FDA Label Image

Droxidopa 200mg 1000 (Droxidopa 200mg 1000ct)

Label for Droxidopa Capsules 200 mg, oral dosage form, supplied by ScieGen Pharmaceuticals Inc. The label states each capsule contains 200 mg of droxidopa, with a 1000 capsule count. Storage instructions, warnings, and manufacturer details are included alongside a barcode and batch information area.*

FDA Label Image

Droxidopa 200mg 30 (Droxidopa 200mg 30ct)

Label for Droxidopa Capsules 200 mg by ScieGen Pharmaceuticals Inc. The label states each capsule contains 200 mg of droxidopa, with storage instructions and dosage guidance. The package contains 30 capsules, is for prescription use only, and includes a barcode and manufacturer address in Hauppauge, NY.*

FDA Label Image

Droxidopa 200mg 30 (Droxidopa 200mg 90ct)

Droxidopa Capsules 200 mg oral dosage form label with NDC 50228-430-90. The label indicates 90 capsules per container, manufactured by ScieGen Pharmaceuticals Inc. Storage instructions and warnings about child resistance and usage are noted on the label. The label includes a barcode and specifies the product as Rx only.*

FDA Label Image

Droxidopa 300mg 30 (Droxidopa 300mg 30ct)

Droxidopa Capsules 300 mg oral capsules label from ScieGen Pharmaceuticals Inc. The label states the strength as 300 mg with a package count of 30 capsules. It includes storage instructions, warnings, lot and expiration placeholders, and a barcode. The label also notes the prescription-only status and the manufacturer's address in Hauppauge, NY.*

FDA Label Image

Droxidopa 300mg 500 (Droxidopa 300mg 500ct)

Droxidopa Capsules 300 mg oral dosage form packaging label showing a 500 capsule count. The label includes storage instructions, dosage directions, and a warning to keep out of reach of children. Manufactured by ScieGen Pharmaceuticals Inc, with the NDC 50228-431-05 and a barcode displayed on the right side.*

FDA Label Image

Droxidopa 300mg 30 (Droxidopa 300mg 90ct)

Label for Droxidopa Capsules 300 mg from ScieGen Pharmaceuticals Inc. The label states the product contains 90 capsules and is for prescription use only. It includes a barcode, storage instructions, and warnings such as keeping out of reach of children. The label dimensions indicated are 0.90 x 1.50 inches with no varnish.*

FDA Label Image

Mean Change In Ohsa (Droxidopa Fig01)

Line graph showing the mean change in dizziness over eight weeks in a double-blind treatment phase comparing Droxidopa and placebo groups. The graph displays baseline values and subsequent weekly changes, with Droxidopa showing a greater reduction in dizziness than placebo, particularly significant at week 1 (p < 0.05). Error bars indicate variability in both groups across the study period.*

FDA Label Image

Distribution Of Patients By Change In Ohsa (Droxidopa Fig02)

A bar graph comparing the percent of subjects reporting improvement in OHSA Question 1 between Placebo and Droxidopa groups. The x-axis shows improvement scores from -8 (worse) to 8 (better), and the y-axis shows the percentage of subjects. The graph uses bars for Placebo and Droxidopa data to depict the distribution of responses across improvement scores.*

FDA Label Image

Droxidopa-01 (Droxidopa Str)

Chemical structure of droxidopa, showing its molecular components including hydroxyl groups, an amine group, and a carboxyl group attached to a benzene ring and carbon backbone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.